CDKN2B Antikörper
Kurzübersicht für CDKN2B Antikörper (ABIN1449282)
Target
Alle CDKN2B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- This antibody reacts with p15INK4b (15 kDa).
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human (HeLa, 293T, transfectant), does not react with Mouse (NIH/3T3, P3U1) and Rat (PC12, Rat1)
-
Aufreinigung
- Protein A agarose
-
Immunogen
- GST-full length human p15INK4b
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS containing 50 % glycerol, pH 7.2. Contains no preservatives.
-
Konservierungsmittel
- Without preservative
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Upon receipt, store (in aliqouts) at -20 °C.
-
-
- CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
-
Andere Bezeichnung
- CDKN2B / p15INK4b
-
Hintergrund
- Progression through the G1 phase of the cell cycle is regulated in part by the D-type cyclin-dependent kinases, cdk4 and cdk6. p15INK4b is a specific inhibitor of cdk4/cdk6 and is periodically expressed during cell cycle. Induction of p15INK4b is important for TGFß-mediated cytostasis in epithelial cells but not in hematopoietic cells, it may act as an effector of TGF-ß mediated cell arrest.Synonyms: Cyclin-dependent kinase 4 inhibitor B, MTS2, Multiple tumor suppressor 2, p14-INK4b, p14INK4b, p15-INK4b
-
Gen-ID
- 1030
-
NCBI Accession
- NP_004927
-
UniProt
- P42772
-
Pathways
- Zellzyklus, Mitotic G1-G1/S Phases
Target
-